Literature DB >> 806533

Rhipicephalus sanguineus: vector of a new spotted fever group rickettsia in the United States.

W Burgdorfer, D J Sexton, R K Gerloff, R L Anacker, R N Philip, L A Thomas.   

Abstract

A rickettsia related to but distinct from the spotted fever agent, Rickettsia rickettsii, has been detected in 167 (18.9%) of 884 Rhipicephalus sanguineus taken off dogs in central and northern Mississippi. The organisms could readily be isolated in male meadow voles (Microtus pennsylvanicus), where it produced massive infections in the tissues of tunica vaginalis. It was practically nonpathogenic for male guinea pigs, although inoculation of these animals with infected tunica vaginalis of voles afforded in 30 of 38 instances solid immunity to challenge with virulent R. rickettsii. The Rhipicephalus rickettsia grew well in monolayers of chicken embryo fibroblast, Vero, mouse L, and HeLa cells. Cytopathogenic effects were minimal unless large concentrations of rickettsiae were used as inocula. It also could be established in embryonated hen eggs but only after injection of massive doses of L cell-propagated organisms. Serological tests (complement fixation, microagglutination and/or micro immunofluorescence) indicated that the newly described Rickettsia belongs to the spotted fever group but differs from R. rickettsii, R. akari, and R. conorii. Antigenic differences were also demonstrated by direct fluorescence microscopy as well as by vaccine potency and mouse-toxin neutralization tests.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 806533      PMCID: PMC415268          DOI: 10.1128/iai.12.1.205-210.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  STAINING RICKETTSIAE IN YOLK-SAC CULTURES.

Authors:  D F GIMENEZ
Journal:  Stain Technol       Date:  1964-05

2.  Spotted fever vaccine; potency assay by direct challenge of vaccinated mice with toxin of Rickettsia rickettsii.

Authors:  E J BELL; H G STOENNER
Journal:  J Immunol       Date:  1961-12       Impact factor: 5.422

3.  A toxic substance associated with the rickettsias of the spotted fever group.

Authors:  E J BELL; E G PICKENS
Journal:  J Immunol       Date:  1953-05       Impact factor: 5.422

4.  Rapid fluorescent-antibody conjugation procedure.

Authors:  M Peacock; W Burgdorfer; R A Ormsbee
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

5.  A historical account of the rickettsial diseases with a discussion of unsolved problems.

Authors:  T E Woodward
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

6.  A microagglutination technique for detection and measurement of rickettsial antibodies.

Authors:  P Fiset; R A Ormsbee; R Silberman; M Peacock; S H Spielman
Journal:  Acta Virol       Date:  1969-01       Impact factor: 1.162

7.  Purification of Rickettsia rickettsi by density-gradient zonal centrifugation.

Authors:  R L Anacker; R K Gerloff; L A Thomas; R E Mann; W R Brown; W D Bickel
Journal:  Can J Microbiol       Date:  1974-11       Impact factor: 2.419

8.  Hemolymph test. A technique for detection of rickettsiae in ticks.

Authors:  W Burgdorfer
Journal:  Am J Trop Med Hyg       Date:  1970-11       Impact factor: 2.345

9.  Studies of the rickettsial plaque assay technique.

Authors:  D A Wike; G Tallent; M G Peacock; R A Ormsbee
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

10.  Plaque assay of rickettsiae in a mammalian cell line.

Authors:  J Cory; C E Yunker; R A Ormsbee; M Peacock; H Meibos; G Tallent
Journal:  Appl Microbiol       Date:  1974-06
  10 in total
  31 in total

1.  In vitro studies of rickettsia-host cell interactions: ultrastructural changes induced by Rickettsia rickettsii infection of chicken embryo fibroblasts.

Authors:  D J Silverman; C L Wisseman
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

2.  Isolation and identification of Rickettsia massiliae from Rhipicephalus sanguineus ticks collected in Arizona.

Authors:  Marina E Eremeeva; Elizabeth A Bosserman; Linda J Demma; Maria L Zambrano; Dianna M Blau; Gregory A Dasch
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

3.  Reactivity of monoclonal antibodies to Rickettsia rickettsii with spotted fever and typhus group rickettsiae.

Authors:  R L Anacker; R E Mann; C Gonzales
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

4.  Analysis of fluorescent protein expression in transformants of Rickettsia monacensis, an obligate intracellular tick symbiont.

Authors:  Gerald D Baldridge; Nicole Burkhardt; Michael J Herron; Timothy J Kurtti; Ulrike G Munderloh
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

5.  Taxonomic relationships among spotted fever group rickettsiae as revealed by antigenic analysis with monoclonal antibodies.

Authors:  W Xu; D Raoult
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

6.  Antigenic heterogeneity in high- and low-virulence strains of Rickettsia rickettsii revealed by monoclonal antibodies.

Authors:  R L Anacker; R H List; R E Mann; D L Wiedbrauk
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

Review 7.  Rocky Mountain spotted fever: a disease in need of microbiological concern.

Authors:  D H Walker
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

8.  Ultrastructure of Rickettsia rhipicephali, a new member of the spotted fever group rickettsiae in tissues of the host vector Rhipicephalus sanguineus.

Authors:  S F Hayes; W Burgdorfer
Journal:  J Bacteriol       Date:  1979-01       Impact factor: 3.490

9.  Isolation on "VERO" cells of a spotted fever group rickettsia "Mortilli strain" from Rhipicephalus sanguineus.

Authors:  G Tringali; V Intonazzo; A M Perna; S Mansueto; D H Walker
Journal:  Eur J Epidemiol       Date:  1986-09       Impact factor: 8.082

10.  Microimmunofluorescence test for the serological study of rocky mountain spotted fever and typhus.

Authors:  R N Philip; E A Casper; R A Ormsbee; M G Peacock; W Burgdorfer
Journal:  J Clin Microbiol       Date:  1976-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.